Home Newsfeeds Wolfe Research Initiates Coverage On Medtronic with Underperform Rating

Wolfe Research Initiates Coverage On Medtronic with Underperform Rating

Wolfe Research analyst Mike Polark initiates coverage on Medtronic (NYSE:MDT) with a Underperform rating.

byBenzinga Newsdesk

July 6, 2022

1 minute read

Wolfe Research analyst Mike Polark initiates coverage on Medtronic (NYSE:MDT) with a Underperform rating.

Immix Biopharma Announces Late-Breaking NXC-201 Clinical Data Abstract Accepted For Oral Presentation At The 26th Annual Meeting Of The American Society Of Gene And Cell Therapy

By Happy Mohamed

May 4, 12:31 PM

Immix Biopharma, Inc. (NASDAQ:IMMX) ("ImmixBio", "Company", "We" or "Us") today announced that updated NXC-201 clinical data has been selected for presentation at the upcoming 26th

IMMX

Analyst Ratings

The Latest Analyst Ratings for LifeMD

By Benzinga Insights

November 30, 3:00 PM

Analysts have provided the following ratings for LifeMD (NASDAQ:LFMD) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…

LFMD

Market Volatility Increases After Fed Minutes; S&P 500 Settles Lower

By Lisa Levin

July 6, 5:58 AM

The S&P 500 settled lower on Wednesday following minutes from the U.S. Federal Reserve's recent meeting. U.S. factory orders rose 0.3% month-over-month for May, versus market expectations for a 0.8% growth. The Philadelphia SE Semiconductor Index fell around 2.2%, with Intel Corporation (NASDAQ: INTC.O) shares losing over 3% on Wednesday.

AAPL